Protective effect of resolvin E1 on the development of asthmatic airway inflammation

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 128-133

  Aoki, Haruka ^a   Hisada, Takeshi ^a   Ishizuka, Tamotsu ^a   Utsugi, Mitsuyoshi ^a   Ono, Akihiro ^a   Koga, Yasuhiko ^a   Sunaga, Noriaki ^a   Nakakura, Takashi ^b   Okajima, Fumikazu ^b   Dobashi, Kunio ^b   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Airway hyperresponsiveness; Airway inflammation; Bronchial asthma; Lipid mediator; Resolvin

Indexed keywords

CYTOKINE; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; RESOLVIN E1; UNCLASSIFIED DRUG; 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; TH2 CELL; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BRONCHIAL HYPERREACTIVITY; DISEASE MODEL; IMMUNOLOGY; PATHOLOGY; PNEUMONIA;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; FEMALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA;

MURINAE; MUS;

EID: 79251592284     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.025     Document Type: Article

References (21)

1. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000, 192:1197-1204.
2. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002, 196:1025-1037.
3. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
4. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., Serhan C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 2005, 102:7671-7676.
5. Hasturk H., Kantarci A., Ohira T., Arita M., Ebrahimi N., Chiang N., Petasis N.A., Levy B.D., Serhan C.N., Van Dyke T.E. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006, 20:401-403.
6. Busse W.W., Lemanske R.F. Asthma, N. Engl. J. Med. 2001, 344:350-362.
7. Aoki H., Hisada T., Ishizuka T., Utsugi M., Kawata T., Shimizu Y., Okajima F., Dobashi K., Mori M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem. Biophys. Res. Commun. 2008, 367:509-515.
8. Haworth O., Cernadas M., Yang R., Serhan C.N., Levy B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 2008, 9:873-879.
9. Hisada T., Ishizuka T., Aoki H., Mori M. Resolvin E1 as a novel agent for the treatment of asthma. Expert Opin. Ther. Targets 2009, 13:513-522.
10. Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 2008, 8:193-204.
11. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., Gelfand E.W. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 1997, 156:766-775.
12. Koike Y., Hisada T., Utsugi M., Ishizuka T., Shimizu Y., Ono A., Murata Y., Hamuro J., Mori M., Dobashi K. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am. J. Respir. Cell Mol. Biol. 2007, 37:322-329.
13. Lampinen M., Carlson M., Hakansson L.D., Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004, 59:793-805.
14. Arita M., Ohira T., Sun Y.P., Elangovan S., Chiang N., Serhan C.N. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 2007, 178:3912-3917.
15. + T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J. Immunol. 2004, 172:2549-2558.
16. + T cells mediate inflammation and airway hyper-responsiveness. Nat. Med. 2004, 10:865-869.
17. Miyahara N., Takeda K., Miyahara S., Matsubara S., Koya T., Joetham A., Krishnan E., Dakhama A., Haribabu B., Gelfand E.W. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2005, 172:161-167.
18. + T cells and airway hyperresponsiveness. J. Immunol. 2005, 174:4979-4984.
19. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N.A., Serhan C.N. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 2005, 201:713-722.
20. Vassiliou E.K., Kesler O.M., Tadros J.H., Ganea D. Bone marrow-derived dendritic cells generated in the presence of resolvin E1 induce apoptosis of activated CD4+ T cells. J. Immunol. 2008, 181:4534-4544.
21. Hammad H., Lambrecht B.N. Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation. J. Allergy Clin. Immunol. 2006, 118:331-336.